Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
1 | 40640900 | 0 | Mokhtar G, Abdelbaky A, Adly A, et al. Egyptian pediatric guidelines for the management of childhood venous thromboembolism: the adapted methodology: a limited resource country perspective. Thromb J. 2025 Jul 10;23(1):74. doi: 10.1186/s12959-025-00758-0. |
2 | 40561511 | 0 | Kawtharany H, Azzam M, Alkhader A, et al. Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis. Blood Adv. 2025 Jun 25:bloodadvances.2025017058. doi: 10.1182/bloodadvances.2025017058. |
3 | 40423983 | 0 | Monagle P, Azzam M, Bercovitz R, et al. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Blood Adv. 2025 May 27;9(10):2587-2636. doi: 10.1182/bloodadvances.2024015328. |
4 | 40379105 | 0 | Al-Huniti AH, Malcolmson C, Langlois V, et al. Benefits of Anticoagulation Prophylaxis in Children Undergoing Kidney Transplant: Systematic Review and Meta-Analysis. J Thromb Haemost. 2025 May 14:S1538-7836(25)00322-8. doi: 10.1016/j.jtha.2025.04.032. |
5 | 40353824 | 0 | Avila L, Di Ruggiero E, Vincelli J, et al. Global Survey on Practice Changes and Barriers to the Use of Direct Oral Anticoagulants in Children. Blood Adv. 2025 May 12:bloodadvances.2025016681. doi: 10.1182/bloodadvances.2025016681. |
6 | 40316285 | 0 | Srichumpuang C, Kor-Anantakul P, Brandao LR, et al. Compound heterozygous congenital protein C deficiency: a challenging management with recurrent purpura fulminans treated with protein C concentrations. BMJ Case Rep. 2025 May 2;18(5):e263471. doi: 10.1136/bcr-2024-263471. |
7 | 39830972 | 0 | Bastas D, Mancini A, Wong G, et al. Health literacy in pediatric thrombosis: a landscape analysis. Res Pract Thromb Haemost. 2024 Dec 9;9(1):102653. doi: 10.1016/j.rpth.2024.102653. eCollection 2025 Jan. |
8 | 39798923 | 0 | Betensky M, Albisetti M, Biss T, et al. Systematic Analysis of the Design, Methodology and Patient Population Characteristics of the Pediatric Direct Oral Anticoagulant (DOAC) Trials of Venous Thromboembolism Treatment. J Thromb Haemost. 2025 Jan 9:S1538-7836(24)00790-6. doi: 10.1016/j.jtha.2024.12.035. |
9 | 39321425 | 0 | Betensky M, Mosha M, Tarango C, et al. Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial. Blood Adv. 2024 Nov 26;8(22):5790-5795. doi: 10.1182/bloodadvances.2024014415. |
10 | 39086106 | 0 | Mancini A, Wong G, Bastas D, et al. Reliability, usability, and efficiency of video versus print instructions to teach parents a procedural task: A cross-sectional study. Pediatr Blood Cancer. 2024 Oct;71(10):e31237. doi: 10.1002/pbc.31237. Epub 2024 Jul 31. |